Indian share markets witnessed intensified selloff in the final hour of trading, which dragged the market lower. At the closing bell, BSE Sensex ended down by 425 points, while, NSE Nifty ended down by 126 points.

Barring realty stocks and telecom stocks, all sectoral indices ended in red with automobiles stocks and metal stocks witnessing maximum selling pressure.

Globally, Asian stock markets finished mixed as of the most recent closing prices. The Shanghai Composite gained 1.3%, while the Nikkei 225 led the Hang Seng lower. They fell 2% and 0.2% respectively. European markets are mixed today. The CAC 40 is up 0.1% while the FTSE 100 gains 0.04%. The DAX is off 0.1%.

Pharma stocks ended the day on a mixed note with Lupin & Divis Laboratories leading the gainers. As per an article in a leading financial daily, Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Carbamazepine Extended-Release Tablets in various strengths.

Reportedly, it will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad in the state of Gujarat.

This medication is used to treat certain types of seizures (partial, generalized tonic-clonic, mixed) and certain types of nerve pain (trigeminal and glossopharyngeal neuralgia).

The group now has 248 approvals and has so far filed over 350 ANDAs since the commencement of the filing process in FY 2003-04.

To know more about the company, you can access to Cadila Healthcare's latest result analysis and Cadila Healthcare's stock analysis on our website.

Cadila Healthcare share price ended the day flat.

Moving on to the news from the automobiles sector. Passenger vehicle sales continued to remain under pressure in the new year with wholesale volumes falling 1.9% to 280125 units in January.

As per data with industry body Society of Indian Automobile Manufacturers (SIAM), sales of passenger vehicles stood at 285467 units in the year-ago period.

Sales of commercial vehicles increased marginally by 2.2% to 87591 units.

Three-wheeler sales fell 13.6% to 54043 units in the period under review.

Increase in ownership costs also hurt demand for two-wheelers which declined 5.2% to 1597572 units in January. While sales of motorcycles dropped 2.6% to 1027810 units, those of scooters slid 10.2% to 497169 units.

Overall, sales of vehicles across categories declined 4.7% to 2019331 units.

Speaking of automobiles sector, all the components of BSE Auto index have fallen. Tata Motors have crashed over 60% and Motherson Sumi Systems have plunged over 40% in past one year. While, Bharat Forge, Ashok Leyland and Maruti Suzuki fell over 30% during the same period.

But, one thing we must keep in mind is that not all auto companies will make money over time. And also, you shouldn't stay away from auto stocks altogether.

Even Tanushree Banerjee, Co-head of research at Equitymaster believes that there are businesses in this sector that you cannot ignore. She is particularly talking about the blue-chip auto stocks.

Here's Tanushree:

• One out of every three household in India is a buyer of their products. They own some of the cult brands in Indian automobile space. They have formidable R&D teams. They have been through several economic cycles over decades. Few have even visited near-bankruptcy in the past and come out successful.
  
  Yet, some of the biggest passenger car, commercial vehicle, and two-wheeler companies in India have seen a huge dent in valuations in recent times.
  
  This could be the opportunity long term investors were waiting for.

Automobile stocks ended on a negative note with Tata Motors & Eicher Motors leading the losers.